What kind of medical conditions can be treated by CyberKnife at Medanta?
Non-cancerous tumors: As a good option for ablative dosages, CyberKnife can be used as an effective alternative to surgery. It works by delivering very high ablative dosages in a concentrated manner during a single or small number of sessions.
The precision equal to or even more than Conventional Gamma Knife procedure. Apart from being a valid alternative to surgery, CyberKnife can also be recommended in case of post-op residual or recurrent tumors, or as a boost to conventional radiation therapy.
Brain cancer: In malignant gliomas/glioblastomas, CyberKnife is mainly performed as a boost for post-op residual or recurrent cases. Some types of brain tumors can be treated with CyberKnife radiosurgery. These include neuromas arising from other nerves, hemangioblastomas and meningiomas, pituitary adenomas, and hemangiopericytomas.
Prostate cancer: As the prostate moves unpredictably when the air passes through the rectum or the bladder empties and fills, the flexibility and high precision of CyberKnife Radiosurgery System at Medanta enables the experts to overcome this challenge.
The system helps by continuously identifying the exact location of the prostate in real time while delivering the radiation. It can make active corrections based on any movement of the prostate throughout the radiation treatment.
The CyberKnife Radiosurgery System is now the most frequently used single treatment modality for early stage confined prostate cancers. It can also be in combination with external beam radiotherapy as a boost for patients who have advanced or intermediate stages of prostate cancer.
Medanta radiation oncologists will recommend a treatment plan depending on the stage of the patient’s prostate cancer to suit the patient’s needs.
Liver cancer: With liver cancer also, radiation therapy poses a challenge as liver tumors move with breathing and the tissue surrounding the tumors is very sensitive. Medanta CyberKnife Radiosurgery System allows the doctors to deliver very high doses of radiation to both primary liver cancer (pre- or post- liver transplant or with chemotherapy or other treatments) and metastatic liver tumors with extreme accuracy.
The CyberKnife System at Medanta for liver cancer works in conjunction with the Synchrony Respiratory Tracking System. It enables the system delivering the radiation beam to track tumor movement in real time. The patients can breathe normally during their treatment sessions. The doctors at Medanta are then able to track the moving target – the liver tumor and deliver radiation without unnecessary damage to the healthy surrounding tissue.
Spine cancer: CyberKnife allows sparing normal spinal cord with more precision in comparison to the most other radiation therapy techniques. Local therapy in spinal tumours can also be done with CyberKnife as it delivers highly focused radiation that helps in sparing the surrounding normal tissues.
Lung cancer: Early stage Lung Cancers is a good indication for CyberKnife as it is limited to a small area. CyberKnife also helps patients with lung metastasis or post primary treatment for limited residual or recurrent disease. The oncologist at Medanta can target this.
Head and Neck Cancer: Usually, CyberKnife is used as a boost for the small critical area near the eyes or other vital areas. The benefit is that it decrease the dose exposure to the vital areas and subsequent side effects. It is also indicated for post-primary therapy residual and recurrent disease, Recurrent disease, or Neck node residual.
Breast Cancer: CyberKnife can be used for localized early stage Breast Cancers as a very short course of Radiotherapy. It allows targeting the postoperative surgical site. The oncologist at Medanat evaluates the patient’s case and discuss this decision with other specialists based on all available records and stage of the patient
